Cancer as a mitochondrial metabolic disease
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical mechanism-based reasoning with no new empirical human data
OpenAlex W1510071269 · doi:10.3389/fcell.2015.00043
What was done
The author conducted a narrative review examining nuclear-cytoplasm transfer experiments to evaluate the somatic mutation theory of cancer against the hypothesis that cancer is primarily a mitochondrial metabolic disease rooted in Otto Warburg's original framework.
What was found
The abstract reports no quantitative data, sample sizes, or effect sizes. It qualitatively states that findings from nuclear-cytoplasm transfer experiments are difficult to reconcile with the somatic mutation theory and are consistent with cancer being primarily a mitochondrial metabolic disease.
Why it matters
The paper synthesizes mechanistic literature to challenge the prevailing somatic mutation model of carcinogenesis in favor of a mitochondrial metabolic etiology.
Limits
This is a narrative review with no systematic search methodology, no quantitative data, and no direct clinical or patient outcome measurements described in the abstract.
Cited by
- context Nobel laureate Albert Szent-Györgyi first proposed the 'oncogenic paradox' regarding how diverse unrelated agents elicit the common outcome of dysregulated cell growth.
- supports Otto Warburg was the first to define cancer as a metabolic disease.